blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3511004

EP3511004 - COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  31.05.2024
Database last updated on 03.08.2024
FormerGrant of patent is intended
Status updated on  28.01.2024
FormerExamination is in progress
Status updated on  09.01.2024
FormerGrant of patent is intended
Status updated on  05.09.2023
FormerExamination is in progress
Status updated on  04.12.2020
FormerRequest for examination was made
Status updated on  30.11.2020
FormerGrant of patent is intended
Status updated on  22.07.2020
FormerRequest for examination was made
Status updated on  17.01.2020
FormerThe application has been published
Status updated on  14.06.2019
Most recent event   Tooltip24.07.2024Change - representative 
Applicant(s)For all designated states
Immutep S.A.S.
Parc les Algorithmes
Bâtiment 7 - Le Pythagore
Route de I'Orme - RD128
91190 Saint-Aubin / FR
[2024/10]
Former [2019/29]For all designated states
Immutep S.A.S.
Parc Club Orsay
2 Rue Jean Rostand
91400 Orsay / FR
Inventor(s)01 / TRIEBEL, Frédéric
10 rue Saint-Louis
F-78000 Versailles / FR
 [2019/29]
Representative(s)Reddie & Grose LLP
The White Chapel Building 10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2019/29]Thornton, Neil
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
Application number, filing date19158672.619.12.2014
[2019/29]
Priority number, dateGB2013002262619.12.2013         Original published format: GB 201322626
[2019/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3511004
Date:17.07.2019
Language:EN
[2019/29]
Type: B1 Patent specification 
No.:EP3511004
Date:03.07.2024
Language:EN
[2024/27]
Search report(s)(Supplementary) European search report - dispatched on:EP02.04.2019
ClassificationIPC:A61K31/47, A61K31/282, A61K38/16, C07K14/705, A61P35/00
[2019/29]
CPC:
A61K38/1774 (EP,KR,US); A61K31/282 (US); A61K31/4745 (EP,KR,US);
A61K31/555 (EP,KR,US); A61K45/06 (EP,KR,US); A61P35/00 (EP,KR);
A61P43/00 (EP); C07K14/70503 (EP,KR,US); A61K2300/00 (KR);
C07K2319/30 (EP,KR,US) (-)
C-Set:
A61K31/4745, A61K2300/00 (US,EP);
A61K31/555, A61K2300/00 (EP,US);
A61K38/1774, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/08]
Former [2019/29]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:KOMBINATIONSPRÄPARATE ZUR BEHANDLUNG VON KREBS[2019/29]
English:COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER[2019/29]
French:PRÉPARATIONS COMBINÉES POUR LE TRAITEMENT DU CANCER[2019/29]
Examination procedure14.01.2020Amendment by applicant (claims and/or description)
14.01.2020Examination requested  [2020/08]
14.01.2020Date on which the examining division has become responsible
23.07.2020Communication of intention to grant the patent
27.11.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.12.2020Despatch of a communication from the examining division (Time limit: M06)
10.06.2021Reply to a communication from the examining division
13.08.2021Despatch of a communication from the examining division (Time limit: M06)
08.02.2022Reply to a communication from the examining division
27.05.2022Despatch of a communication from the examining division (Time limit: M06)
06.12.2022Reply to a communication from the examining division
06.09.2023Communication of intention to grant the patent
08.01.2024Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
29.01.2024Communication of intention to grant the patent
28.05.2024Fee for grant paid
28.05.2024Fee for publishing/printing paid
28.05.2024Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14830806.7  / EP3089749
Divisional application(s)EP24178618.5  / EP4414035
Fees paidRenewal fee
21.02.2019Renewal fee patent year 03
21.02.2019Renewal fee patent year 04
21.02.2019Renewal fee patent year 05
13.12.2019Renewal fee patent year 06
14.12.2020Renewal fee patent year 07
10.11.2021Renewal fee patent year 08
14.11.2022Renewal fee patent year 09
15.11.2023Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2009032256  (CELL GENESYS INC [US], et al);
 [A]WO2009044273  (IMMUTEP [FR], et al);
by applicantWO2009044273
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.